Cited by 1,107Nanoparticle-Based Drug DeliveryBarrier Structure and Function StudiesDrug Transport and Resistance Mechanisms

The DOI matches its Crossref record; 47 of the 50 references it cites were found in a registry or an index.

Nanoparticulate systems for brain delivery of drugs.

Kreuter, Jörg·2001·Advanced Drug Delivery Reviews

DOI 10.1016/s0169-409x(00)00122-8

Open this paper in CoChat — free account

Abstract

The blood--brain barrier (BBB) represents an insurmountable obstacle for a large number of drugs, including antibiotics, antineoplastic agents, and a variety of central nervous system (CNS)-active drugs, especially neuropeptides. One of the possibilities to overcome this barrier is a drug delivery to the brain using nanoparticles. Drugs that have successfully been transported into the brain using this carrier include the hexapeptide dalargin, the dipeptide kytorphin, loperamide, tubocurarine, the NMDA receptor antagonist MRZ 2/576, and doxorubicin. The nanoparticles may be especially helpful for the treatment of the disseminated and very aggressive brain tumors. Intravenously injected doxorubicin-loaded polysorbate 80-coated nanoparticles were able to lead to a 40% cure in rats with intracranially transplanted glioblastomas 101/8. The mechanism of the nanoparticle-mediated transport of the drugs across the blood-brain barrier at present is not fully elucidated. The most likely mechanism is endocytosis by the endothelial cells lining the brain blood capillaries. Nanoparticle-mediated drug transport to the brain depends on the overcoating of the particles with polysorbates, especially polysorbate 80. Overcoating with these materials seems to lead to the adsorption of apolipoprotein E from blood plasma onto the nanoparticle surface. The particles then seem to mimic low density lipoprotein (LDL) particles and could interact with the LDL receptor leading to their uptake by the endothelial cells. After this the drug may be released in these cells and diffuse into the brain interior or the particles may be transcytosed. Other processes such as tight junction modulation or P-glycoprotein (Pgp) inhibition also may occur. Moreover, these mechanisms may run in parallel or may be cooperative thus enabling a drug delivery to the brain.

Integrity signals

Registry

Crossref · 10.1016/s0169-409x(00)00122-8

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites.
Cordon‐Cardo, C., O’Brien, J. P., Casals, D., Rittmann-Grauer, L., Biedler, J. L., Melamed, M. R., & Bertino, J. R. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.2.695 · Cited by 1,750
Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins
Pitas, R. E., Boyles, J. K., Lee, S. H., Foss, D., & Mahley, R. W. (1987) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(87)90295-5 · Cited by 693
Brain drug delivery of small molecules using immunoliposomes
Huwyler, J., Wu, D., & Pardridge, W. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.14164 · Cited by 660
An Easier, Reproducible, and Mass‐Production Method to Study the Blood–Brain Barrier In Vitro
Dehouck, M., Méresse, S., Delorme, P., Fruchart, J., & Cecchelli, R. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb01236.x · Cited by 548
Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles)
Kreuter, J., Alyautdin, R. N., Kharkevich, D. A., & Aa, I. (1995) · Brain Research · doi:10.1016/0006-8993(95)00023-j · Cited by 538
Significant Transport of Doxorubicin into the Brain with Polysorbate 80-Coated Nanoparticles
Gulyaev, A. E., Gelperina, S. E., Skidan, I. N., Antropov, A. S., Kivman, G. Y., & Kreuter, J. (1999) · Pharmaceutical Research · doi:10.1023/a:1018983904537 · Cited by 521
A New Function for the LDL Receptor: Transcytosis of LDL across the Blood–Brain Barrier
Dehouck, B., Fenart, L., Dehouck, M.-P., Pierce, A., Torpier, G., & Cecchelli, R. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.138.4.877 · Cited by 490
Hyperalgesia Induced by Naloxone Follows Diurnal Rhythm in Responsivity to Painful Stimuli
Frederickson, R. C. A., Burgis, V., & Edwards, J. D. (1977) · Science · doi:10.1126/science.561998 · Cited by 379
Selective transport of an anti-transferrin receptor antibody through the blood-brain barrier in vivo.
Pardridge, W. M., Buciak, J. L., & Friden, P. M. (1991) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20567-5 · Cited by 358
Delivery of Loperamide Across the Blood-Brain Barrier with Polysorbate 80-Coated Polybutylcyanoacrylate Nanoparticles
Alyautdin, R. N., Petrov, V. E., Langer, K., Berthold, A., Kharkevich, D. A., & Kreuter, J. (1997) · Pharmaceutical Research · doi:10.1023/a:1012098005098 · Cited by 352

Show all 50 references

Research works printed but not linked: 6

Kreuter, 1994, Nanoparticles, Vol. 10, 165
Alyautdin, 1995, Analgesic activity of the hexapeptide dalargin adsorbed on the surface of polysorbate 80-coated poly(butyl cyanoacrylate) nanoparticles, Eur. J. Pharm. Biopharm., 41, 44
Ramge, 2000, Polysorbate 80-coating enhances uptake of polybutylcyanoacrylate (PBCA)-nanoparticles by human, bovine and murine primary brain capilary endothelial cells, Eur. J. Neuro., 12, 1935
Steiniger, 1999, The influence of polysorbate 80-coated nanoparticles on bovine brain capillary endothelial cells in vitro, Proc. Int. Symp. Control. Rel. Bioact. Mater., 26, 789
Fenart, 1999, Evaluation of effect of charge and lipid coating on ability of 60-nm nanoparticles to cross an in vitro model of the blood–brain barrier, J. Pharmacol. Exp. Ther., 291, 1017
Cecchelli, 1997, Receptor-mediated transcytosis of blood-borne molecules through blood–brain barrier endothelial cells: Drug targeting by endogenous transport routes, Proc. Intl. Symp. Control. Rel. Bioact. Mater., 24, 221

Sorted by citations

Items 301–400 of 1,000

In Vivo and in Vitro Assessment of Baseline Blood-Brain Barrier Parameters in the Presence of Novel Nanoparticles
Lockman, P. R., Koziara, J. M., Roder, K. E., Paulson, J. R., Abbruscato, T. J., Mumper, R. J., & Allen, D. D. (2003) · Pharmaceutical Research · doi:10.1023/a:1023492015851 · Cited by 92
Enhanced accumulation of curcumin and temozolomide loaded magnetic nanoparticles executes profound cytotoxic effect in glioblastoma spheroid model
Dilnawaz, F., & Sahoo, S. K. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.07.013 · Cited by 95
Antiangiogenic Therapy and Mechanisms of Tumor Resistance in Malignant Glioma
Rahman, R., Smith, S. J., Rahman, C. V., & Grundy, R. G. (2010) · Journal of Oncology · doi:10.1155/2010/251231 · Cited by 91
How to Make Anticancer Drugs Cross the Blood–Brain Barrier to Treat Brain Metastases
Angeli, E., Nguyen, T. T., Janin, A., & Bousquet, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010022 · Cited by 93
PLA/PLGA nanoparticles for delivery of drugs across the blood-brain barrier
Li, J., & Sabliov, C. M. (2013) · Nanotechnology Reviews · doi:10.1515/ntrev-2012-0084 · Cited by 90
Targeted Doxorubicin Delivery to Brain Tumors via Minicells: Proof of Principle Using Dogs with Spontaneously Occurring Tumors as a Model
MacDiarmid, J. A., Langová, V., Bailey, D. L., Pattison, S. T., Pattison, S. L., Christensen, N. I., Armstrong, L., Brahmbhatt, V. N., Smolarczyk, K., Harrison, M. T., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151832 · Cited by 89
Novel docetaxel-loaded nanoparticles based on PCL-Tween 80 copolymer for cancer treatment
Mei, L., Zeng, Cheng, Zheng, Z., Song, Huang, & -, M. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s25251 · Cited by 90
Identifying lipidic emulsomes for improved oxcarbazepine brain targeting: In vitro and rat in vivo studies
El-Zaafarany, G. M., Soliman, M. E., Mansour, S., & Awad, G. A. S. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.02.038 · Cited by 89
Drug delivery: advancements and challenges
Singh, N., Joshi, A., Toor, A. P., & Verma, G. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-46143-6.00027-0 · Cited by 88
Recent advances in benefits and hazards of engineered nanoparticles
Radad, K., Al-Shraim, M. M., Moldzio, R., & Rausch, W. (2012) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2012.07.011 · Cited by 88
Biodistribution and long-term fate of silver nanoparticles functionalized with bovine serum albumin in rats
Garza‐Ocañas, L., Ferrer, D. A., Burt, J. L., Diaz-Torres, L. A., Cabrera, M. R., Rodríguez, V. T., Rangel, R. L., Romanovicz, D. K., & José–Yacamán, M. (2009) · Metallomics · doi:10.1039/b916107d · Cited by 88
In Vitro Investigation on Poly(lactide)−Tween 80 Copolymer Nanoparticles Fabricated by Dialysis Method for Chemotherapy
Zhang, Z., & Feng, S. (2006) · Biomacromolecules · doi:10.1021/bm050953v · Cited by 88
Challenges towards Targeted Drug Delivery in Cancer Nanomedicines
Hafeez, M. N., Celia, C., & Petrikaitė, V. (2021) · Processes · doi:10.3390/pr9091527 · Cited by 91
Conjugation of Functionalized SPIONs with Transferrin for Targeting and Imaging Brain Glial Tumors in Rat Model
Jiang, W., Xie, H., Ghoorah, D., Shang, Y., Shi, H., Liu, F., Yang, X., & Xu, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037376 · Cited by 86
Template-free Synthesis and Encapsulation Technique for Layer-by-Layer Polymer Nanocarrier Fabrication
Qi, A., Chan, P. P. Y., Ho, J., Rajapaksa, A. E., Friend, J. R., & Yeo, L. Y. (2011) · ACS Nano · doi:10.1021/nn202833n · Cited by 85
Carbohydrate coated, folate functionalized colloidal graphene as a nanocarrier for both hydrophobic and hydrophilic drugs
Maity, A. R., Chakraborty, A., Mondal, A., & Jana, N. R. (2013) · Nanoscale · doi:10.1039/c3nr05431d · Cited by 85
Noninvasive nanoparticle strategies for brain tumor targeting
Sun, C., Ding, Y., Zhou, L. J., Shi, D., Sun, L., Webster, T. J., & Shen, Y. (2017) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2017.07.009 · Cited by 86
The potential application of iron chelators for the treatment of neurodegenerative diseases
Hider, R. C., Roy, S., Ma, Y. M., Kong, X. L., & Preston, J. E. (2011) · Metallomics · doi:10.1039/c0mt00087f · Cited by 86
Current strategies for targeted delivery of bio-active drug molecules in the treatment of brain tumor
Garg, T., Bhandari, S., Rath, G., & Goyal, A. K. (2015) · Journal of drug targeting · doi:10.3109/1061186x.2015.1029930 · Cited by 86
Design of pH-responsive nanoparticles of terpolymer of poly(methacrylic acid), polysorbate 80 and starch for delivery of doxorubicin
Shalviri, A., Chan, H. K. C., Raval, G., Abdekhodaie, M. J., Liu, Q., Heerklotz, H. H., & Wu, X. Y. (2012) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2012.07.015 · Cited by 84
Nanomedicine: A Promising Way to Manage Alzheimer’s Disease
Khan, N. H., Mir, M., Ngowi, E. E., Zafar, U., Khakwani, M. M. A. K., Khattak, S., Zhai, Y., Jiang, E., Zheng, M., Duan, S., et al. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.630055 · Cited by 84
Effects of Nanoparticles on the Adhesion and Cell Viability on Astrocytes
Au, C., Mutkus, L. A., Dobson, A. W., Riffle, J. S., Lalli, J. H., & Aschner, M. (2007) · Biological Trace Element Research · doi:10.1007/s12011-007-0067-z · Cited by 86
A Biomimetic Nanodecoy Traps Zika Virus To Prevent Viral Infection and Fetal Microcephaly Development
Rao, L., Wang, W., Meng, Q., Tian, M., Cai, B., Wang, Y., Li, A., Zan, M., Xiao, F., Bu, L., et al. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b03913 · Cited by 83
Zinc oxide nanoparticles as a substitute for zinc oxide or colistin sulfate: Effects on growth, serum enzymes, zinc deposition, intestinal morphology and epithelial barrier in weaned piglets
Wang, C., Zhang, L., Su, W., Ying, Z., He, J., Zhang, L., Zhong, X., & Wang, T. Z. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181136 · Cited by 80
Preparation and properties of poly(vinyl alcohol)-stabilized liposomes
Xiao-mei, M., & Zhong, Z. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.03.016 · Cited by 80
Starch-coated magnetic liposomes as an inhalable carrier for accumulation of fasudil in the pulmonary vasculature
Nahar, K., Absar, S., Patel, B., & Ahsan, F. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.01.007 · Cited by 80
Intravenous administration of trans-resveratrol-loaded TPGS-coated solid lipid nanoparticles for prolonged systemic circulation, passive brain targeting and improved in vitro cytotoxicity against C6 glioma cell lines
Vijayakumar, M. R., Kumari, L., Patel, K. K., Vuddanda, P. R., Vajanthri, K. Y., Mahto, S. K., & Singh, S. K. (2016) · RSC Advances · doi:10.1039/c6ra10777j · Cited by 80
Application of Chitosan, Chitooligosaccharide, and Their Derivatives in the Treatment of Alzheimer’s Disease
Ouyang, Q., Zhao, S. X., Li, S., & Song, C. (2017) · Marine Drugs · doi:10.3390/md15110322 · Cited by 78
Delivery of hydrophobised 5-fluorouracil derivative to brain tissue through intravenous route using surface modified nanogels
Soni, S., Babbar, A. K., Sharma, R. K., & Maitra, A. (2006) · Journal of drug targeting · doi:10.1080/10611860600635608 · Cited by 79
Body distribution of polysorbate‐80 and doxorubicin-loaded [14C]poly(butyl cyanoacrylate) nanoparticles after i.v. administration in rats
Ambruosi, A., Yamamoto, H., & Kreuter, J. (2005) · Journal of drug targeting · doi:10.1080/10611860500411043 · Cited by 79
Neuro-nanotechnology: diagnostic and therapeutic nano-based strategies in applied neuroscience
Shabani, L., Abbasi, M., Azarnew, Z., Amani, A. M., & Vaez, A. (2023) · BioMedical Engineering OnLine · doi:10.1186/s12938-022-01062-y · Cited by 82
Nanoparticle based Drug Delivery Systems for Treatment of Infectious Diseases
Salouti, M., & Ahangari, A. (2014) · InTech eBooks · doi:10.5772/58423 · Cited by 78
Nanoneurotherapeutics approach intended for direct nose to brain delivery
Md, S., Mustafa, G., Baboota, S., & Ali, J. (2015) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2015.1052081 · Cited by 78
Peptide- and Aptamer-Functionalized Nanovectors for Targeted Delivery of Therapeutics
Pangburn, T. O., Petersen, M. A., Waybrant, B., Adil, M. M., & Kokkoli, E. (2009) · Journal of Biomechanical Engineering · doi:10.1115/1.3160763 · Cited by 80
A review of the current understanding of nanoparticles protein corona composition
Breznica, P., Koliqi, R., & Daka, A. (2020) · Medicine and Pharmacy Reports · doi:10.15386/mpr-1756 · Cited by 84
Particle Surface Design using an All‐Dry Encapsulation Method
Lau, K. K. S., & Gleason, K. K. (2006) · Advanced Materials · doi:10.1002/adma.200600896 · Cited by 77
Curcumin-loaded polymeric nanoparticles for neuroprotection in neonatal rats with hypoxic-ischemic encephalopathy
Joseph, A., Wood, T. R., Chen, C., Corry, K. A., Snyder, J. M., Juul, S. E., Parikh, P., & Nance, E. A. (2018) · Nano Research · doi:10.1007/s12274-018-2104-y · Cited by 79
Uptake, excretion and toxicity of nano-sized latex particles on medaka (Oryzias latipes) embryos and larvae
Manabe, M., Tatarazako, N., & Kinoshita, M. (2011) · Aquatic Toxicology · doi:10.1016/j.aquatox.2011.08.020 · Cited by 76
Transport of Poly(n-butylcyano-acrylate) nanoparticles across the blood–brain barrier in vitro and their influence on barrier integrity
Rempe, R. G., Cramer, S., Hüwel, S., & Galla, H. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.01.110 · Cited by 76
Nanotherapeutics engineered to cross the blood-brain barrier for advanced drug delivery to the central nervous system
Kim, J., Ahn, S. I., & Kim, Y. (2019) · Journal of Industrial and Engineering Chemistry · doi:10.1016/j.jiec.2019.01.021 · Cited by 76
Nanotechnology applications and approaches for neuroregeneration and drug delivery to the central nervous system
Silva, G. A. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05361.x · Cited by 75
Nano-enabled delivery systems across the blood–brain barrier
Hwang, S. R., & Kim, K. (2013) · Archives of Pharmacal Research · doi:10.1007/s12272-013-0272-6 · Cited by 74
Brain-targeted delivery of Tempol-loaded nanoparticles for neurological disorders
Carroll, R. T., Bhatia, D., Geldenhuys, W. J., Bhatia, R., Miladore, N., Bishayee, A., & Sutariya, V. B. (2010) · Journal of drug targeting · doi:10.3109/10611861003639796 · Cited by 75
Design and Evaluation of Chitosan Nanoparticles As Novel Drug Carrier for the Delivery of Rivastigmine to Treat Alzheimer‘s Disease
Wilson, B., Samanta, M. K., Muthu, M. S., & Vinothapooshan, G. (2011) · Therapeutic Delivery · doi:10.4155/tde.11.21 · Cited by 74
Macromolecular drug transport into the brain using targeted therapy
Lichota, J., Skjørringe, T., Thomsen, L. B., & Moos, T. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06544.x · Cited by 75
Current Opinion on Nanotoxicology
Pourmand, A., & Abdollahi, M. R. (2012) · DARU Journal of Pharmaceutical Sciences · doi:10.1186/2008-2231-20-95 · Cited by 74
Preparation and optimization of surface-treated methotrexate-loaded nanogels intended for brain delivery
Azadi, A., Hamidi, M., Khoshayand, M., Amini, M., & Rouini, M. R. (2012) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2012.05.066 · Cited by 73
ImprovingIn VivoEfficacy of Bioactive Molecules: An Overview of Potentially Antitumor Phytochemicals and Currently Available Lipid-Based Delivery Systems
Mouhid, L., Corzo‐Martínez, M., Torres, C. F., Vázquez, L., Reglero, G., Fornari, T., & de Molina, A. R. (2017) · Journal of Oncology · doi:10.1155/2017/7351976 · Cited by 76
New Approaches for Cryptococcosis Treatment
Spadari, C. D. C., Wirth, F., Lopes, L. B., & Ishida, K. (2020) · Microorganisms · doi:10.3390/microorganisms8040613 · Cited by 79
Nanotherapeutic systems for local treatment of brain tumors
Chakroun, R. W., Zhang, P., Lin, R., Schiapparelli, P. V., Quiñones‐Hinojosa, A., & Cui, H. (2017) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1479 · Cited by 80
Enhanced oral bioavailability and brain uptake of Darunavir using lipid nanoemulsion formulation
Desai, J. L., & Thakkar, H. P. (2018) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2018.11.057 · Cited by 70
Selegiline Nanoformulation in Attenuation of Oxidative Stress and Upregulation of Dopamine in the Brain for the Treatment of Parkinson's Disease
Kumar, S., Dang, S., Nigam, K., Ali, J., & Baboota, S. (2018) · Rejuvenation Research · doi:10.1089/rej.2017.2035 · Cited by 70
Biopolymer Nanoparticles for Nose-to-Brain Drug Delivery: A New Promising Approach for the Treatment of Neurological Diseases
Montegiove, N., Calzoni, E., Emiliani, C., & Cesaretti, A. (2022) · Journal of Functional Biomaterials · doi:10.3390/jfb13030125 · Cited by 70
Targeting regulation of ABC efflux transporters in brain diseases: A novel therapeutic approach
Potschka, H. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.10.004 · Cited by 71
Therapeutic approaches of magnetic nanoparticles for the central nervous system
Dilnawaz, F., & Sahoo, S. K. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.06.008 · Cited by 71
Development of highly efficient nanocarrier-mediated delivery approaches for cancer therapy
Jeong, K., Kang, C. S., Kim, Y., Lee, Y.-D., Kwon, I. C., & Kim, S. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.01.050 · Cited by 70
Solid Lipid Nanoparticles for Ocular Delivery of Isoniazid: Evaluation, Proof of Concept and In Vivo Safety & Kinetics
Singh, M., Guzmán‐Aránguez, A., Hussain, A., Srinivas, C. S., & Kaur, I. P. (2019) · Nanomedicine · doi:10.2217/nnm-2018-0278 · Cited by 68
Sumatriptan succinate loaded chitosan solid lipid nanoparticles for enhanced anti-migraine potential
Girotra, P., Singh, S. K., & Kumar, P. (2015) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2015.08.035 · Cited by 68
Drug Delivery to the Spinal Cord Tagged with Nanowire Enhances Neuroprotective Efficacy and Functional Recovery following Trauma to the Rat Spinal Cord
Sharma, H. S., Ali, S. F., Dong, W., Tian, Z. R., PATNAIK, R., Patnaik, S., Sharma, A., Boman, A., Lek, P. M., Seifert, E., et al. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1403.014 · Cited by 68
Brain targeting with surface-modified poly(d,l-lactic-co-glycolic acid) nanoparticles delivered via carotid artery administration
Tahara, K., Miyazaki, Y., Kawashimà, Y., Kreuter, J., & Yamamoto, H. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.11.002 · Cited by 68
Targeting Nevirapine Delivery Across Human Brain Microvascular Endothelial Cells Using Transferrin-Grafted Poly(Lactide- Co -Glycolide) Nanoparticles
Kuo, Y., Lin, P., & Wang, C. (2011) · Nanomedicine · doi:10.2217/nnm.11.25 · Cited by 68
Characterization of liposome-containing SPIONs conjugated with anti-CD20 developed as a novel theranostic agent for central nervous system lymphoma
Saesoo, S., Sathornsumetee, S., Anekwiang, P., Treetidnipa, C., Thuwajit, P., Bunthot, S., Maneeprakorn, W., Maurizi, L., Hofmann, H., Ruktanonchai, U., et al. (2017) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2017.11.003 · Cited by 68
The Use of Nanoparticles for Gene Therapy in the Nervous System
Pérez‐Martínez, F. C., Carrión, B., & Ceña, V. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120661 · Cited by 69
Advances in strategies to improve drug delivery to brain tumors
Newton, H. B. (2006) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.6.10.1495 · Cited by 67
Crossing the blood-brain barrier: Glutathione-conjugated poly(ethylene imine) for gene delivery
Englert, C., Trützschler, A., Raasch, M., Buś, T., Borchers, P., Mosig, A. S., Traeger, A., & Schubert, U. S. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.08.039 · Cited by 68
Solid lipid nanoparticles for delivery of Calendula officinalis extract
Arana, L., Salado, C., Vega, S., Aizpurua‐Olaizola, O., de la Arada, I., Suárez, T., Usobiaga, A., Arrondo, J. L. R., Alonso, A., Goñi, F. M., et al. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.07.020 · Cited by 67
Nanoparticle-Guided Brain Drug Delivery: Expanding the Therapeutic Approach to Neurodegenerative Diseases
Riccardi, C., Napolitano, F., Montesarchio, D., Sampaolo, S., & Melone, M. A. B. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13111897 · Cited by 70
Surface functionalized nanoparticles: A boon to biomedical science
Upadhyay, K., Tamrakar, R. K., Thomas, S., & Kumar, M. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110537 · Cited by 67
Brain targeting of Atorvastatin loaded amphiphilic PLGA-b-PEG nanoparticles
Şimşek, S., Eroğlu, H., Kürüm, B., & Ulubayram, K. (2012) · Journal of Microencapsulation · doi:10.3109/02652048.2012.692400 · Cited by 66
Nanomaterial applications for neurological diseases and central nervous system injury
Huang, L., Hu, J., Huang, S., Wang, B. Z., Siaw-Debrah, F., Nyanzu, M. K., Zhang, Y., & Zhuge, Q. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.07.003 · Cited by 66
Neurotherapeutic applications of nanomedicine for treating Alzheimer's disease
Wilson, B., & Geetha, K. M. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.05.044 · Cited by 67
Nanoparticle-mediated growth factor delivery systems: A new way to treat Alzheimer's disease
Lauzon, M.-A., Daviau, A., Marcos, B., & Faucheux, N. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.03.024 · Cited by 66
Drug delivery across the blood–brain barrier: why is it difficult? how to measure and improve it?
Su, Y., & Sinko, P. J. (2006) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.3.3.419 · Cited by 65
Tissue inhibitor of matrix metalloproteinases-1 loaded poly(lactic-co-glycolic acid) nanoparticles for delivery across the blood–brain barrier
Chaturvedi, M., Molino, Y., Sreedhar, B., Khrestchatisky, M., & Kaczmarek, L. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s54750 · Cited by 65
Brain targeted oral delivery of doxycycline hydrochloride encapsulated Tween 80 coated chitosan nanoparticles against ketamine induced psychosis: behavioral, biochemical, neurochemical and histological alterations in mice
Yadav, M., Parle, M., Sharma, N., Dhingra, S., Raina, N., & Jindal, D. K. (2017) · Drug Delivery · doi:10.1080/10717544.2017.1377315 · Cited by 65
Enhanced blood–brain barrier penetration and glioma therapy mediated by T7 peptide-modified low-density lipoprotein particles
Liang, M., Gao, C., Wang, Y., Gong, W., Fu, S., Cui, L., Zhou, Z., Chu, X., Zhang, Y., Liu, Q., et al. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1494223 · Cited by 64
Nanoparticle mediated brain targeted delivery of gallic acid:in vivobehavioral and biochemical studies for improved antioxidant and antidepressant-like activity
Nagpal, K., Singh, S. K., & Mishra, D. N. (2012) · Drug Delivery · doi:10.3109/10717544.2012.738437 · Cited by 65
Cytotoxicity Effects of Different Surfactant Molecules Conjugated to Carbon Nanotubes on Human Astrocytoma Cells
Dong, L., Witkowski, C. M., Craig, M., Greenwade, M. M., & Joseph, K. L. (2009) · Nanoscale Research Letters · doi:10.1007/s11671-009-9429-0 · Cited by 63
Brain-targeted delivery of doxorubicin using glutathione-coated nanoparticles for brain cancers
Geldenhuys, W. J., Wehrung, D., Groshev, A., Hirani, A., & Sutariya, V. B. (2014) · Pharmaceutical Development and Technology · doi:10.3109/10837450.2014.892130 · Cited by 63
New Perspectives of HPMA‐based Copolymers Derived by Post‐Polymerization Modification
Nuhn, L., Barz, M., & Zentel, R. (2014) · Macromolecular Bioscience · doi:10.1002/mabi.201400028 · Cited by 65
Preparation and investigation of solid lipid nanoparticles for drug delivery
Kalaycıoğlu, G. D., & Aydoğan, N. (2016) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2016.06.034 · Cited by 63
Preparation of multifunctional Janus nanoparticles on the basis of SPIONs as targeted drug delivery system
Shaghaghi, B., Khoee, S., & Bonakdar, S. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.01.020 · Cited by 64
Glial cell line-derived neurotrophic factor-conjugated nanoparticles suppress acquisition of cocaine self-administration in rats
Green-Sadan, T., Kuttner, Y., Lublin‐Tennenbaum, T., Kinor, N., Boguslavsky, Y., Margel, S., & Yadid, G. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.01.020 · Cited by 64
Investigation and modeling effective parameters influencing the size of BSA protein nanoparticles as colloidal carrier
Rahimnejad, M., Najafpour, G. D., & Bakeri, G. (2012) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2012.07.022 · Cited by 62
Pluronic P85-coated poly(butylcyanoacrylate) nanoparticles overcome phenytoin resistance in P-glycoprotein overexpressing rats with lithium-pilocarpine-induced chronic temporal lobe epilepsy
Fang, Z., Chen, S., Qin, J., Chen, B., Ni, G., Chen, Z., Zhou, J., Li, Z., Ning, Y., Wu, C., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.04.021 · Cited by 64
Recent progress in drug delivery systems for anticancer agents
Kim, C., & Lim, S. (2002) · Archives of Pharmacal Research · doi:10.1007/bf02976620 · Cited by 61
Nanostructure-based drug delivery systems for brain targeting
Haque, S., Md, S., Alam, M. I., Sahni, J. K., Ali, J., & Baboota, S. (2011) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2011.608191 · Cited by 62
Nanobiomaterials’ applications in neurodegenerative diseases
Silva‐Adaya, D., Aguirre‐Cruz, L., Guevara, J., & Ortiz-Islas, E. (2016) · Journal of Biomaterials Applications · doi:10.1177/0885328216659032 · Cited by 62
Natural Brain Penetration Enhancer-Modified Albumin Nanoparticles for Glioma Targeting Delivery
Liang, J., Gao, C., Zhu, Y., Ling, C., Wang, Q., Huang, Y., Qin, J., Wang, J., Lu, W., & Wang, J. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b11782 · Cited by 61
Loading efficiency of stavudine on polybutylcyanoacrylate and methylmethacrylate-sulfopropylmethacrylate copolymer nanoparticles
Kuo, Y. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.11.025 · Cited by 61
The Benefits of Macromolecular/Supramolecular Approaches in Hydrogen Sulfide Delivery: A Review of Polymeric and Self-Assembled Hydrogen Sulfide Donors
Kaur, K., Carrazzone, R. J., & Matson, J. B. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7864 · Cited by 60
Nanoparticles and Colloidal Hydrogels of Chitosan–Caseinate Polyelectrolyte Complexes for Drug-Controlled Release Applications
Lall, A., Tamo, A. K., Doench, I., David, L., Oliveira, P. F., Gorzelanny, C., & Osorio‐Madrazo, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165602 · Cited by 60
Polymers as Efficient Non-Viral Gene Delivery Vectors: The Role of the Chemical and Physical Architecture of Macromolecules
Khan, M. (2024) · Polymers · doi:10.3390/polym16182629 · Cited by 64
The efficacy and safety of bufadienolides-loaded nanostructured lipid carriers
Li, F., Weng, Y., Wang, L., He, H., Yang, J., & Tang, X. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.04.005 · Cited by 60
Pharmacokinetics and Tissue Distribution of Etoposide Delivered in Parenteral Emulsion
Patlolla, R. R., & Vobalaboina, V. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20249 · Cited by 59
Solid lipid nanoparticles carrying chemotherapeutic drug across the blood–brain barrier through insulin receptor-mediated pathway
Kuo, Y., & Shih-Huang, C.-Y. (2013) · Journal of drug targeting · doi:10.3109/1061186x.2013.812094 · Cited by 59
Intranasal delivery of tetrabenazine nanoemulsion via olfactory region for better treatment of hyperkinetic movement associated with Huntington’s disease: Pharmacokinetic and brain delivery study
Arora, A., Kumar, S., Ali, J., & Baboota, S. (2020) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2020.104917 · Cited by 59
Particle size analysis of nanocrystals: Improved analysis method
Keck, C. M. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.08.042 · Cited by 59
Thioflavins released from nanoparticles target fibrillar amyloid β in the hippocampus of APP/PS1 transgenic mice
Siegemund, T., Paulke, B. ‐., Schmiedel, H., Bordag, N., Hoffmann, A. H., Harkany, T., Tanila, H., Kacza, J., & Härtig, W. (2005) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2005.11.012 · Cited by 60
Brain-Targeted Drug Delivery
Bodor, N. S., & Buchwald, P. (2003) · American Journal of Drug Delivery · doi:10.2165/00137696-200301010-00002 · Cited by 62

Authors: Kreuter, J.
Affiliations: Goethe University Frankfurt (DE)
Corresponding author: Kreuter, Jörg
Venue: Advanced Drug Delivery Reviews
Publisher: Elsevier BV
Published: 2001-03
Volume: 47
Issue: 1
Pages: 65-81
ISSN: 0169-409X (ISSN-L)
DOI: 10.1016/s0169-409x(00)00122-8
OpenAlex: W2072229818
Cited by: 1,107
References: 50
Citations by year: 2026: 15 · 2025: 20 · 2024: 26 · 2023: 39 · 2022: 32 · 2021: 43 · 2020: 47 · 2019: 40 · 2018: 47 · 2017: 53 · 2016: 63 · 2015: 57 · 2014: 55 · 2013: 65 · 2012: 76
FWCI: 1.84
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Advanced Drug Delivery Reviews (publishedVersion)
PubMed (publishedVersion)
Topics: Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Keywords: blood-brain barrier, nanoparticle drug delivery, brain drug delivery, apolipoprotein E, glioblastoma, doxorubicin, neuropeptides, P-glycoprotein inhibition, tight junction modulation, transcytosis, central nervous system drugs
MeSH terms: Animals, Antineoplastic Agents, Blood-Brain Barrier, Brain, Brain Neoplasms, Capsules, Cells, Cultured, Doxorubicin, Drug Carriers, Endothelium, Vascular, Humans, Male, Polysorbates, Surface-Active Agents, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Nanoparticulate systems for brain delivery of drugs.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Citations

Cites

Cited by

Related

Metadata

Record

About these checks